Trial | NCT00658255  Report issue

Title

Relative Bronchodilating Effects of Formoterol When Administered Via Symbicort Pressurized Metered-dose Inhaler (pMDI) or Oxis Turbuhaler
A Randomized, Multicenter, Open-label, Active-controlled, Single-dose, 5-period, Incomplete Block, Cross-over Study to Evaluate the Relative Bronchodilating Effects of Formoterol When Administered Via Symbicort pMDI or Oxis Turbuhaler to Adults With Stable Asthma

  • Phase

    Phase 2

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    175
The purpose of this study is to compare the therapeutic effects of formoterol in Symbicort with formoterol in Oxis Turbuhaler for the treatment of adults with stable asthma.
Study Started
Oct 31
2002
Study Completion
May 31
2003
Last Update
Jan 24
2011
Estimate

Drug budesonide/formoterol

  • Other names: Symbicort

Drug formoterol

  • Other names: Oxis Turbuhaler

1 Experimental

2 Active Comparator

Criteria 

Inclusion Criteria:

At least 18 years of age
Diagnosis of asthma and baseline lung function tests as determined by the protocol
Required and received treatment with inhaled corticosteroids within timeframe and doses specified in the protocol

Exclusion Criteria:

Severe asthma
Has required treatment with any non-inhaled corticosteroids within previous 4 weeks, has sensitivity to drugs specified in protocol or requires treatment with beta-blockers
No Results Posted